A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics

AGOURA HILLS, Calif., Nov. 5, 2019 -- (Healthcare Sales & Marketing Network)-- A2 Biotherapeutics (www.a2bio.com), a biotechnology company developing innovative cell therapies for cancer patients, today announced its official launch. The company, founded...Biopharmaceuticals, Oncology, Venture Capital, Personnel
A2 Biotherapeutics, Selective Tumor Cell Therapeutics